https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-122006-10-01 00:00:002019-02-15 08:32:38Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-602006-10-01 00:00:002019-02-15 08:35:53[Clinical impact of locoregional hyperthermia in gynecological oncology]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-42006-10-01 00:00:002019-02-15 08:51:26Current status of immunotherapy in B cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-482006-09-27 00:00:002019-02-15 08:59:54Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-18 / Int. J. Radiat. Oncol. Biol. Phys. 2006 Nov;66(4):1159-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-18 / Int. J. Radiat. Oncol. Biol. Phys. 2006 Nov;66(4):1159-672006-09-18 00:00:002019-02-15 08:35:26Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB „bulky“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-15 / Cancer 2006 Sep;107(6):1373-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-15 / Cancer 2006 Sep;107(6):1373-822006-09-15 00:00:002006-09-15 00:00:00Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-14 / N. Engl. J. Med. 2006 Sep;355(11):1179-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-14 / N. Engl. J. Med. 2006 Sep;355(11):1179-812006-09-14 00:00:002019-02-15 09:19:46Patient-specific dendritic-cell vaccines for metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-72006-09-05 00:00:002019-02-15 08:53:27Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / Apoptosis 2006 Sep;11(9):1513-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / Apoptosis 2006 Sep;11(9):1513-242006-09-01 00:00:002019-02-15 08:38:16Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-413
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-4132006-09-01 00:00:002019-02-15 08:45:17Dendritic cell-based immunotherapy
